» Articles » PMID: 10652353

Rho-associated Kinase ROCK Activates LIM-kinase 1 by Phosphorylation at Threonine 508 Within the Activation Loop

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Feb 1
PMID 10652353
Citations 225
Authors
Affiliations
Soon will be listed here.
Abstract

LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization. LIMK1 is activated by the small GTPase Rho and its downstream protein kinase ROCK. We now report the site of phosphorylation of LIMK1 by ROCK. In vitro kinase reaction revealed that the active forms of ROCK phosphorylated LIMK1 on the threonine residue and markedly increased its cofilin-phosphorylating activity. A LIMK1 mutant (T508A) with replacement of Thr-508 within the activation loop of the kinase domain by alanine was neither phosphorylated nor activated by ROCK. Replacement of Thr-508 by serine changed the ROCK-catalyzed phosphorylation residue from threonine to serine. A LIMK1 mutant with replacement of Thr-508 by two glutamates increased the kinase activity about 2-fold but was not further activated by ROCK. In addition, wild-type LIMK1, but not its T508A mutant, was activated by co-expression with ROCK in cultured cells. These results suggest that ROCK activates LIMK1 in vitro and in vivo by phosphorylation at Thr-508. Together with the recent finding that PAK1, a downstream effector of Rac, also activates LIMK1 by phosphorylation at Thr-508, these results suggest that activation of LIMK1 is one of the common targets for Rho and Rac to reorganize the actin cytoskeleton.

Citing Articles

Identification of (PDZ-RhoGEF) as an in vivo regulator of synapses and cognition.

Bjornson K, Kermath B, Cahill M Proc Natl Acad Sci U S A. 2025; 122(4):e2415316122.

PMID: 39835891 PMC: 11789018. DOI: 10.1073/pnas.2415316122.


LIM kinases in cardiovascular health and disease.

Lateef O, Foote C, Power G, Manrique-Acevedo C, Padilla J, Martinez-Lemus L Front Physiol. 2025; 15():1506356.

PMID: 39744707 PMC: 11688343. DOI: 10.3389/fphys.2024.1506356.


Discovery of MDI-114215: A Potent and Selective LIMK Inhibitor To Treat Fragile X Syndrome.

Baldwin A, Foley D, Collins R, Lee H, Jones D, Wahab B J Med Chem. 2024; 68(1):719-752.

PMID: 39711116 PMC: 11726654. DOI: 10.1021/acs.jmedchem.4c02694.


Structural and functional alterations of neurons derived from sporadic Alzheimer's disease hiPSCs are associated with downregulation of the LIMK1-cofilin axis.

Sollazzo R, Li Puma D, Aceto G, Paciello F, Colussi C, Vita M Alzheimers Res Ther. 2024; 16(1):267.

PMID: 39702316 PMC: 11660640. DOI: 10.1186/s13195-024-01632-3.


Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases.

Ye Q, Li X, Gao W, Gao J, Zheng L, Zhang M Front Neurosci. 2024; 18:1481983.

PMID: 39628659 PMC: 11613983. DOI: 10.3389/fnins.2024.1481983.